Washington University Institute of Clinical and Translational Sciences (UL1)

圣路易斯华盛顿大学（WU）的CTSA申请建立在悠久的机构历史之上 杰出的生物医学研究、研究培训和病人护理。吴是4个临床的收件人 构成CTSA基础的研究和培训赠款（GCRC，目前处于资助的第46年， K12、K30和T32赠款。另一个关键因素是WU新的BioMed 21战略计划， 在基因组科学、生物成像和临床研究方面的多学科合作研究。所有 这些要素将与华盛顿大学的其他现有资源结合起来，形成一个转型的新研究所 临床和转化科学（ICTS）。通过实施 通过这一应用，信息通信技术将在概念上和操作上重塑和重振临床和 转化研究和临床研究培训。 与其他学术，医疗保健，社区和科学的伙伴关系达到前所未有的水平 补充我们在实验室和临床研究以及研究培训方面的核心专业知识的机构是 这将是由信息通信技术领导的转型的核心。我们的合作伙伴包括BJC HealthCare， 综合学术和社区卫生保健提供系统;圣刘易斯大学公共学院 密苏里州圣路易斯大学医学院 护理;南伊利诺伊大学爱德华兹维尔护理学院;和圣路易斯药学院;关键 促进社区健康的组织以及圣。 路易斯区这些资源的耦合为基础实验室的建设创造了良好的环境 这些发现可以转化为临床研究方案，并最终转化为临床研究的进展。 通过广泛的社区互动和商业伙伴关系，实践和病人护理。 为了确保ICTS的成功，WU在空间和资金方面做出了大量承诺。 支持.巴恩斯-犹太和圣路易斯儿童医院，我们的学术医院合作伙伴，以及BJC HeatthCare 7我们的公司也对临床研究做出了实质性的承诺 ICTS的活动。这些额外的资源加上现有的高质量的临床计划， 和转化科学确保吴将作出杰出贡献，这NIH的倡议。

This CTSA application from Washington University in St. Louis (WU) is built on a long institutional history of outstanding biomedical research, research training, and patient care. WU is the recipient of the 4 clinical research and training grants that form the basis of the CTSA (GCRC, currently in its 46th year of funding, and K12, K30, and T32 grants.) Another critical element is WU's new BioMed 21 strategic initiative in multidisciplinary, collaborative research in genome sciences, biological imaging, and clinical investigation. All these elements will be conjoined with other existing resources at WU to form a transformational new Institute of Clinical and Translational Sciences (ICTS). By implementing the 15 key Program Functions described in this application, the ICTS will conceptually and operationally reinvent and reinvigorate clinical and translational research and clinical research training at WU. An unprecedented level of partnership with other academic, healthcare, community and scientific institutions that complement our core expertise in laboratory and clinical research and research training is central to the transformation that will be led by the ICTS. Our partners include BJC HealthCare, an integrated academic and community health care delivery system; Saint Louis University School of Public Health, Graduate School and Doisy College of Health Sciences; University of Missouri St. Louis College of Nursing; Southern Illinois University Edwardsville School of Nursing; and St. Louis College of Pharmacy; key organizations promoting community health as well as biomedical and pharmaceutical companies in the St. Louis area. The coupling of these resources creates an outstanding environment to make basic laboratory discoveries that can then be translated into clinical research protocols and ultimately into advances in clinical practice and patient care through extensive community interactions and commercial partnerships. __T.o ensure the success of the ICTS, WU has made substantial commitments of space and financial support. Barnes-Jewish and St. Louis Children's Hospitals, our academic hospital partners, and BJC HeatthCare7Our afflliale^Tiealtlrrsystern, have also made substantial commitments to the clinical research activities of the ICTS. These additional resources coupled with the existing high quality programs in clinical and translational science ensure that WU will make outstanding contributions to this NIH initiative.